{
  "id": 20772945,
  "title": "Commentary: A black eye for BASF and a heavy burden for Evonik",
  "url": "https://urgent.news/2026/11/19/kommentar-blaues-auge-fur-basf-und-eine-schwere-burde-fur-evonik",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-19T16:51:55.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/meinung/kommentare/kommentar-blaues-auge-fuer-basf-und-eine-schwere-buerde-fuer-evonik/100271350.html"
  },
  "original_language": "de",
  "account": "The planned merger between BASF and Evonik AG has fallen through due to strong opposition, particularly in Nordrhein-Westfalen. As a result, Evonik's stock price dropped to 18 Euro, down from a potential 25 Euro per share that BASF was expected to pay. Evonik must now prove it can achieve a similar valuation as a standalone company. The RAG-Stiftung, Evonik's main shareholder, relies on the company's dividends to cover mining legacy costs. BASF has ended its bid, avoiding a protracted and potentially costly takeover battle.",
  "summary": "The rejection of the merger of the two largest German chemical companies is consistent, but bad news for the future of German and European chemicals.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}